Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many Oxford AstraZeneca covid-19 vaccines administered to people up to the end of June 2021 were manufactured in the Serum Institute of India; and how many of those vaccines were described as (a) Covidshield and (b) Vaxzevria.

All Serum Institute of India (SII) made doses approved by the Medicines and Healthcare products Regulatory Agency (MHRA), supplied through AstraZeneca and administered in the United Kingdom were initially described as ‘COVID-19 vaccine AstraZeneca'. As part of the conditional marketing authorisation approval granted on 24 June 2021, the description was changed amended to ‘Vaxzevria’. No AstraZeneca vaccine described as ‘Covidshield’ has been delivered or administered in the UK.

The information requested on the number of doses manufactured by SII described as ‘Vaxzevria’ administered in the UK is not held centrally.